Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan vs Nebivolol in Acute Ischemic Stroke
NCT03655964Phase 2Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Aug 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olmesartan, nebivolol in hypertension (HTN), sponsored by Aristotle University of Thessaloniki. Started Aug 2018; status: completed.
02
Drugs
olmesartannebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03655964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655964.